Atlas Trials

Clinical Implication of Aflibercept in PCV Treatment in China

Clinical trial NCT05639660 · UNKNOWN

Trial details

NCT number
NCT05639660
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Polypoidal Choroidal Vasculopathy
Start date
2021-01-01
Primary completion
2024-11-20
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.